1 Pasteur Mérieux Connaught, Marnes-la-Coquette, France
The development and licensing of a vaccine for varicella in the United States has taken an incredible length of time. From the first report by Takahashi et al in 1974 until final American licensure in 1995, extensive studies were conducted by many investigators. Despite this long gestation period, which could have produced an elephant, there is some danger that the result will be a mouse, in that use of the vaccine since licensure has been far from universal. Recommendations by the American Academy of Pediatrics' Red Book Commitee and the Advisory Committee on Immunization Practices (statement in preparation, June 1995) may change that picture, but judging from conversations I have had, many American pediatricians have reservations concerning the varicella vaccine.
This article has been cited by other articles:
![]() |
E. T. Luman, P. L. Y. H. Ching, A. O. Jumaan, and J. F. Seward Uptake of Varicella Vaccination Among Young Children in the United States: A Success Story in Eliminating Racial and Ethnic Disparities Pediatrics, April 1, 2006; 117(4): 999 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Katz-Sidlow and R. Sidlow A Look at the Pediatrician as Parent: Experiences with the Introduction of Varicella Vaccine Clinical Pediatrics, September 1, 2003; 42(7): 635 - 640. [Abstract] [PDF] |
||||
![]() |
J. F. Seward, B. M. Watson, C. L. Peterson, L. Mascola, J. W. Pelosi, J. X. Zhang, T. J. Maupin, G. S. Goldman, L. J. Tabony, K. G. Brodovicz, et al. Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000 JAMA, February 6, 2002; 287(5): 606 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Clements, J. I. Zaref, C. L. Bland, E. B. Walter, and P. M. Coplan Partial Uptake of Varicella Vaccine and the Epidemiological Effect on Varicella Disease in 11 Day-Care Centers in North Carolina Arch Pediatr Adolesc Med, April 1, 2001; 155(4): 455 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. N. Loparev, K. McCaustland, B. P. Holloway, P. R. Krause, M. Takayama, and D. S. Schmid Rapid Genotyping of Varicella-Zoster Virus Vaccine and Wild-Type Strains with Fluorophore-Labeled Hybridization Probes J. Clin. Microbiol., December 1, 2000; 38(12): 4315 - 4319. [Abstract] [Full Text] |
||||
![]() |
V. N. Loparev, T. Argaw, P. R. Krause, M. Takayama, and D. S. Schmid Improved Identification and Differentiation of Varicella-Zoster Virus (VZV) Wild-Type Strains and an Attenuated Varicella Vaccine Strain Using a VZV Open Reading Frame 62-Based PCR J. Clin. Microbiol., September 1, 2000; 38(9): 3156 - 3160. [Abstract] [Full Text] |
||||
![]() |
Committee on Infectious Diseases Varicella Vaccine Update Pediatrics, January 1, 2000; 105(1): 136 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Spingarn, J. A. Benjamin, and H. C. Meissner Universal Vaccination against Varicella N. Engl. J. Med., March 5, 1998; 338(10): 683 - 684. [Full Text] |
||||
![]() |
C. E. Johnson, T. Stancin, D. Fattlar, L. P. Rome, and M. L. Kumar A Long-term Prospective Study of Varicella Vaccine in Healthy Children Pediatrics, November 1, 1997; 100(5): 761 - 766. [Abstract] [Full Text] [PDF] |
||||